Zobrazeno 61 - 70
of 479
pro vyhledávání: '"François Aubin"'
Autor:
Jessica Gobbo, Charlée Nardin, Gaëtan Chanteloup, Laura Boullerot, Claire Jacquin-Porretaz, Olivier Adotevi, François Aubin, Carmen Garrido, Marine Cordonnier, Valentin Vautrot
Publikováno v:
Acta Dermato-Venereologica, Vol 99, Iss 12, Pp 1143-1147 (2019)
Exosomes are involved in modulating the immune system and mediating communication between cells. The aim of this study was to investigate the involvement of exosomes in psoriasis. Exosomes from patients with psoriasis were analysed by nanoparticle tr
Publikováno v:
Acta Dermato-Venereologica, Vol 102 (2022)
is missing (Short communication)
Autor:
Anaïs Zanella, Valentin Vautrot, François Aubin, Laure Avoscan, Mahtab Samimi, Carmen Garrido, Jessica Gobbo, Charlée Nardin
Publikováno v:
Experimental Dermatology
Experimental Dermatology, 2022, 31 (6), pp.869-877. ⟨10.1111/exd.14520⟩
Experimental Dermatology, 2022, 31 (6), pp.869-877. ⟨10.1111/exd.14520⟩
International audience; Exosomes, as potential circulated biomarkers, have recently become a topic of interest in the field of oncology. Immune checkpoint molecule PD-L1 has recently been detected in circulating exosomes from cancer patients. The pur
Autor:
Anne-Pauline Bellanger, Louise Vuillemey, François Aubin, Anne-Sophie Gauthier, Bernard Delbosc, Eve Puzenat, Marc Puyraveau, Camille Febvay, Cécile Chagué
Publikováno v:
Journal of the European Academy of Dermatology and Venereology. 36
Autor:
Prudence Colpart, François Aubin, Christophe Borg, Marie Paule Algros, Bruno Heyd, Florian Seckler, Célia Turco, Alexandre Doussot, Charlée Nardin, Paul Calame
Publikováno v:
Journal of Hepatology. 73:1588-1590
Autor:
Irène Gallais Sérézal, François Aubin, Cécile Chagué, Louise Vuillemey, Eve Puzenat, Bernard Delbosc, Anne-Sophie Gauthier, Camille Febvay
Publikováno v:
Annales de Dermatologie et de Vénéréologie - FMC. 1:A55-A56
Introduction Le dupilumab est la premiere biotherapie disponible pour la dermatite atopique (DA). Il repose sur l’inhibition de l’IL-4 et de l’IL-13. Cette therapie peut entrainer des conjonctivites, dont l’incidence est evaluee a 5–28 % se
Autor:
Elisabeth Grimm, Judith Fischer, Adam Majcher, Lionel Van Maldergem, François Aubin, Lukáš Opálka, Robert Pilz, Anne-Claire Bursztejn, Elise Brischoux-Boucher, Roger Sandhoff
Publikováno v:
The FASEB Journal. 35
Autor:
Christoph Hoeller, Marie-Francoise Avril, Pietro Quaglino, François Aubin, Lars Bastholt, Takashi Inozume, Virginia Ferraresi, Michael B. Jameson, Kevin B. Kim, Oliver Bechter, Dirk Schadendorf, Kenji Yokota, Carmen Loquai, Maria-Jose Passos, Inge Marie Svane, Michele Maio, Catherine Barrow, Frank Meiss, Nageatte Ibrahim, Andrzej Mackiewicz, Phillip Parente, Tatsuya Takenouchi, Caroline Dutriaux, Piotr Rutkowski, Alfonsus J M van den Eertwegh, Paola Queirolo, Catriona M. McNeil, Peter Mohr, Felix Kiecker, Susana Puig, Friedegund Meier, Lutz Kretschmer, Alexander C.J. van Akkooi, Alex Menzies, Timothy Crook, Christian U. Blank, Suzana Matkovic, Michael C. Brown, Ragini R. Kudchadkar, Max Levin, Rüdiger Hein, Tanja Skytta, Gerald P. Linette, Clemens Krepler, Adnan Khattak, Ernest Marshall, Joseph Kerger, Oddbjorn Straume, Laurent Mortier, Jochen Utikal, Micaela Hernberg, James Larkin, Yoshio Kiyohara, Mario Mandalà, Henrik Schmidt, Daniil Stroyakovskiy, Pablo Luis Ortiz Romero, Naoya Yamazaki, John Walker, Anna Maria Di Giacomo, Lionel Geoffrois, Jean-Philippe Lacour, Caroline Robert, Vincent Descamps, Shahneen Sandhu, Gil Bar-Sela, Paul C. Nathan, Marcin Dzienis, Ralf Gutzmer, Claus Garbe, Andrey Meshcheryakov, Patrick Combemale, Martin Fehr, Guzel Mukhametshina, Helena Kapiteijn, Geke A. P. Hospers, Jun Aoi, Andrew Haydon, Rutger H. T. Koornstra, Marie-Thérèse Leccia, Sigrun Hallmeyer, Pier Francesco Ferrucci, Jean-Jacques Grob, Leonel Hernandez-Aya, Jan-Christoph Simon, Vanna Chiarion Sileni, Alain Algazi, Lidija Sekulovic, Sandrine Marreaud, Bernard Fitzharris, Jacob Schachter, Xinni Song, Wolf-Henning Boehncke, Rahima Jamal, Paul Lorigan, Maureen J.B. Aarts, Reinhard Dummer, Mike McCrystal, César Martins, Reiner Hofmann-Wellenhof, Alexander M.M. Eggermont, Carola Berking, Elaine Dunwoodie, Bernard Guillot, Michal Kicinski, Philippe Saiag, Céleste Lebbé, Thierry Lesimple, Stefan Suciu, Michal Lotem, Paula Ferreira, Mohammed M. Milhem, Laurent Machet, Patrick Terheyden, Anna Katharina Winge-Main, Peter Hersey, Jean-Francois Baurain, Axel Hauschild, Stéphane Dalle, Jean-Philippe Arnault, Paolo A. Ascierto, Gerard Groenewegen, Florent Grange, Georgina V. Long, Victoria Atkinson, Philippa Corrie, Matteo S. Carlino, Thomas Jouary, Daniel Hendler, Richard Casasola, Ashita Waterston, Jessica C. Hassel
Publikováno v:
EORTC Melanoma Group 2021, ' Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial ', The Lancet Oncology, vol. 22, no. 5, pp. 643-654 . https://doi.org/10.1016/S1470-2045(21)00065-6
Lancet Oncology, 22, 643-654
Lancet Oncology, 22, 5, pp. 643-654
Lancet Oncology
Lancet Oncology, 2021, 22 (5), pp.643-654. ⟨10.1016/S1470-2045(21)00065-6⟩
The Lancet Oncology, 22(5), 643-654. Lancet Publishing Group
Lancet Oncology, 22, 643-654
Lancet Oncology, 22, 5, pp. 643-654
Lancet Oncology
Lancet Oncology, 2021, 22 (5), pp.643-654. ⟨10.1016/S1470-2045(21)00065-6⟩
The Lancet Oncology, 22(5), 643-654. Lancet Publishing Group
Background: The European Organisation for Research and Treatment of Cancer (EORTC) 1325/KEYNOTE-054 trial assessed pembrolizumab versus placebo in patients with resected high-risk stage III melanoma. At 15-month median follow-up, pembrolizumab improv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca46af8de45fdf5ffd9d70f717e94208
https://research.vumc.nl/en/publications/8aae177c-dfa8-4325-b8c2-e7b1d7339027
https://research.vumc.nl/en/publications/8aae177c-dfa8-4325-b8c2-e7b1d7339027
Publikováno v:
The British journal of dermatologyReferences. 185(3)
Autor:
Clément Prati, François Aubin, Frank Verhoeven, Aude Hansmaennel, Mickael Chouk, Daniel Wendling
Publikováno v:
Joint bone spine. 88(5)